ELMD— Electromed, Inc.

Health Care$349M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net revenues	$64.0M+17.0%	$54.7M+13.8%	$48.1M+15.4%	$41.7M
Cost of revenues	$14.0M+8.0%	$13.0M+12.5%	$11.5M+13.0%	$10.2M
Gross profit	$50.0M+19.8%	$41.7M+14.3%	$36.5M+16.1%	$31.4M
Selling, general and administrative	$39.3M+14.0%	$34.5M+9.2%	$31.6M+16.5%	$27.1M
Research and development	$996K+51.8%	$656K-28.4%	$916K-32.4%	$1.4M
Total operating expenses	$40.3M+14.7%	$35.1M+8.1%	$32.5M+14.2%	$28.5M
Operating income	$9.7M+46.8%	$6.6M+64.2%	$4.0M+34.9%	$3.0M
Interest income, net	$624K+37.1%	$455K+483.3%	$78K+212.0%	$25K
Net income before income taxes	$10.3M+46.2%	$7.0M+72.2%	$4.1M+36.3%	$3.0M
Income tax expense	$2.7M+45.7%	$1.9M+105.0%	$920K+32.9%	$692K
Net income	$7.5M+46.3%	$5.2M+62.7%	$3.2M+37.4%	$2.3M
Basic (in dollars per share)	$0.89+48.3%	$0.60+62.2%	$0.37+37.0%	$0.27
Diluted (in dollars per share)	$0.85+46.6%	$0.58+61.1%	$0.36+38.5%	$0.26
Basic (in shares)	8.5M-1.3%	8.6M+1.2%	8.5M-0.1%	8.5M
Diluted (in shares)	8.9M+0.6%	8.9M+1.9%	8.7M-0.8%	8.8M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.